文献速递呼吸衰竭与机械通气儿科与产科急症重症综合管理与镇静镇痛

儿童重型颅脑创伤中的早发性呼吸机相关性肺炎

Early-Onset Ventilator-Associated Pneumonia in Pediatric Severe Traumatic Brain Injury.
PubMed 文献 · Neurocrit Care · 2023-01-12
一句话结论儿童重型颅脑创伤中呼吸机相关性肺炎发生率为27%–41%,与存活出院者功能状态评分较差相关(8 vs 7.5, P=0.048)。

这项回顾性队列研究在四级转诊儿童医院(一级创伤中心)纳入2015–2020年收治的0–18岁、需有创通气至少2天的重型颅脑创伤患儿90例,描述呼吸机相关性肺炎(VAP)的微生物学及不同定义下的发生率差异,并分析VAP相关临床变量。CDC定义VAP占27%,医师诊断的临床VAP增至41%;最常见分离菌为甲氧西林敏感金黄色葡萄球菌,其次为流感嗜血杆菌,多数VAP发生于插管第2–5天。VAP与死亡率无关,但与存活出院者功能状态量表评分较差相关(8 vs 7.5, P=0.048)。累积用药日分析显示雾化3%高渗盐水与沙丁胺醇与VAP发生率降低相关;作者认为需进一步研究祛痰药能否降低儿童重型颅脑创伤VAP发生率。

要点

  • CDC定义VAP占27%,医师诊断的临床VAP占41%,两种定义差异提示需要标准化VAP定义。
  • VAP患儿年龄更大(8.5 vs 5.6岁, P=0.03),且较少遭遇虐待性颅脑创伤(P=0.01)。
  • 最常见分离菌为甲氧西林敏感金黄色葡萄球菌,其次为流感嗜血杆菌,多数VAP发生于插管第2–5天。
  • VAP与死亡率无关,但与存活出院者功能状态量表评分较差相关(8 vs 7.5, P=0.048)。
  • 累积用药日分析显示雾化3%高渗盐水与沙丁胺醇与VAP发生率降低相关;作者认为需进一步研究祛痰药的作用。

适用人群与场景

  • 0–18岁、2015–2020年收入儿科重症监护室、重型颅脑创伤、需要有创通气至少2天的患儿。
  • 单中心四级转诊儿童医院,具有一级创伤中心资质。

诊断标准与关键阈值

  • VAP定义采用疾病控制中心(CDC)定义,或基于医师诊断的临床VAP。

研究设计与关键结果

  • 回顾性队列研究,单中心,纳入90例患儿,比较VAP与非VAP患者的人口学、创伤与损伤数据及结局,关联用回归模型检验。
  • VAP患儿年龄更大(8.5 vs 5.6岁, P=0.03),较少遭遇虐待性颅脑创伤(P=0.01)。
  • 接受持续神经肌肉阻滞或目标温度管理的患儿VAP发生率无差异。
  • CDC定义VAP占27%,医师诊断或临床VAP增至41%。
  • 最常见分离菌为甲氧西林敏感金黄色葡萄球菌,其次为流感嗜血杆菌,多数VAP发生于插管第2–5天。
  • VAP与死亡率无关,但与存活出院者功能状态量表评分较差相关(8 vs 7.5, P=0.048)。
  • 累积用药日分析显示雾化3%高渗盐水与沙丁胺醇与VAP发生率降低相关。

证据类型、等级与局限

  • 证据类型:回顾性队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,雾化3%高渗盐水与沙丁胺醇与VAP发生率降低相关,未来需进一步研究祛痰药能否降低儿童重型颅脑创伤VAP发生率。
  • 临床VAP与CDC定义VAP之间的差异进一步说明需要标准化的VAP定义。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Early-onset ventilator-associated pneumonia (VAP) is associated with poor outcomes in patients with severe traumatic brain injury (TBI). The primary aim of this study was to describe VAP, including the microbiology of VAP and differences in frequency of VAP when various definitions are applied. The secondary aim was to determine the clinical variables associated with the development of VAP in children with severe TBI.

METHODS: This is a retrospective cohort study at a quaternary referral children's hospital with a level I trauma center designation. Inclusion criteria were patients aged 0-18 years admitted to the pediatric intensive care unit between 2015 and 2020 with severe TBI requiring at least 2 days of invasive ventilation. VAP was defined by using Center of Disease Control (CDC) definition or clinical VAP, based on physician diagnosis. We compared general demographics, reviewed trauma and injury data, and outcomes to assess any differences between patients with VAP and non-VAP patients. Associations were tested with regression models.

RESULTS: After applying all inclusion and exclusion criteria, 90 patients were included in the analysis. Patients with VAP were older (8.5 vs. 5.6 years, P = 0.03). Patients with VAP were less likely to have suffered from abusive head trauma (P = 0.01). Patients who received continuous neuromuscular blockade or targeted temperature management did not have different frequencies of VAP. CDC-defined VAP was diagnosed in 27% of patients. Number of patients with VAP increased to 41% for physician-diagnosed or clinical VAP. Methicillin-sensitive Staphylococcus aureus was the most common isolate grown, followed by Hemophilus influenza, with most VAP occurring on days 2-5 of intubation. VAP was not associated with mortality but was associated with worse functional status scale in patients who survived to discharge (8 vs. 7.5, P = 0.048). Over a cumulative period of days, nebulized 3% and albuterol were associated with decreased incidence of VAP.

CONCLUSIONS: Ventilator-associated pneumonia occurs commonly in children with severe TBI, with rates of 27-41%, depending on CDC-defined VAP or clinical VAP. The discrepancy between clinical VAP and CDC-defined VAP further illustrates the need for a standardized definition for VAP. Although most interventions were not associated with VAP, nebulized 3% saline and albuterol were associated with reduced incidence of VAP; future investigation is needed to determine whether mucolytic agents can decrease the rate of VAP in children with severe TBI.

来源:Neurocrit Care,查看原文。版权归原作者所有。

参考来源

  1. Gahagen RE, Beardsley AL, Maue DK, et al. Early-Onset Ventilator-Associated Pneumonia in Pediatric Severe Traumatic Brain Injury. Neurocrit Care. 2023. PMID: 36635493. doi:10.1007/s12028-022-01663-4

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。